Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03535909
Other study ID # RS-2018-S01
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 9, 2018
Est. completion date July 31, 2018

Study information

Verified date March 2019
Source Rodin Scientific LLC
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study will assess the ability of a novel optical measurement system to determine changes in the hemodynamic status of heart failure patients admitted to the hospital with a primary diagnosis of acute decompensated heart failure. Patients will be measured with both the novel measurement system and reference devices that are FDA-cleared for hemodynamic measurements. The measurements from the novel system will be compared to reference variables describing hemodynamic and congestive status, including stroke volume, central venous pressure, and serum levels of NT-proBNP.


Description:

This study will assess the ability of a novel optical measurement system to determine changes in the hemodynamic status of heart failure patients admitted to the hospital with a primary diagnosis of acute decompensated heart failure. Patients will be measured with both the novel measurement system and reference devices that are FDA-cleared for hemodynamic measurements. The measurements from the novel system will be compared to reference variables describing hemodynamic and congestive status, including stroke volume, central venous pressure, and serum levels of NT-proBNP.

All patients enrolled in the study will first provide written informed consent to participate and then the research coordinator will check that the subject meets all study inclusion criteria and does not meet any of the study exclusion criteria. Enrolled subjects will undergo up to six (6) hemodynamic assessment sessions lasting less than 90 minutes each over the course of their hospitalization. There will be at least eight (8) hours between assessment sessions.

Each assessment session includes recording of the subject's weight, measurements with the reference devices, and measurements with the novel optical system. During the session, the subject will be assessed in the supine, sitting, and standing positions. NT-proBNP measurements will be done at the start of study participation and the end. A market research questionnaire will be administered to the subject following the first measurement session.


Recruitment information / eligibility

Status Completed
Enrollment 5
Est. completion date July 31, 2018
Est. primary completion date June 24, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Age = 18 years

- Admission to the hospital with a primary diagnosis of acute decompensated heart failure

- Treated with or planned treatment with intravenous diuretics

- Volume overload, as indicated by at least one of the following clinical signs:

- Peripheral edema

- Pulmonary edema on physical examination

- Pleural effusions on chest x-ray

- Jugular venous distension on physical examination

- CVP > 10 cmH2O

- Presence of third heart sound

- Able to understand study procedures, agree to participate in the study program and voluntarily provide written informed consent

Exclusion Criteria:

- Inability or refusal to sign the Subject Informed Consent

- Age > 80 years

- Body mass index (BMI) > 40

- Planned mechanical ventilation during hospitalization

- Presence of left ventricular assist device (LVAD)

- Dialysis

- Pregnancy. All women of childbearing potential must have a negative pregnancy test before enrollment.

- Parenteral diuretic or other medical treatment for ADHF already administered for more than 12 hours prior to enrollment

- Skin damage to the optical sampling sites (fingers and dorsal hand), to include tattoos, scars, cuts, or burns extending over more than 30% of the visible tissue

- Compromised superficial hand veins or proximal venous stenosis

- Intravenous lines connected to both arms

- Inability to stand with support, if needed, for 4 minutes

- Inability to place hand in the venous imaging enclosure due to forearm, elbow, or shoulder injuries, or other physical constraints

- Inability to wear fingertip or ring sensors on three fingers (of either hand) due to missing fingers, injured fingers, or other physical constraints

- Persons in police custody or prisoners

- Major medical or psychiatric condition that would interfere with the ability to complete the study

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Noninvasive Hemodynamic Measurement System
Ability of the noninvasive hemodynamic measurement system to determine changes in the hemodynamic status of heart failure patients admitted to the hospital with a primary diagnosis of acute decompensated heart failure.

Locations

Country Name City State
Croatia University Hospital of Split Split
United States New Mexico Heart Institute Albuquerque New Mexico

Sponsors (2)

Lead Sponsor Collaborator
Rodin Scientific LLC University of Split, School of Medicine

Countries where clinical trial is conducted

United States,  Croatia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Accuracy of Estimated Changes in Stroke Volume Comparison of Stroke Volume Measurement (units of ml) from the optical measurement system with paired Stroke Volume Measurement (ml) from the reference device. Accuracy will be measured in percentage error and Bland-Altman limits of agreement. Retrospective up to 6 months after study completion
Secondary Accuracy of Central Venous Pressure Measurement Comparison of Central Venous Pressure Measurement (units of cmH2O) from the optical measurement system with paired Central Venous Pressure Measurement (cmH2O) from the reference device. Accuracy will be measured in percentage error and Bland-Altman limits of agreement. Retrospective up to 6 months after study completion
See also
  Status Clinical Trial Phase
Terminated NCT04115735 - His Bundle Recording From Subclavian Vein
Recruiting NCT05562037 - Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA N/A
Completed NCT05563701 - Evaluation of the LVivo Image Quality Scoring (IQS)
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Completed NCT04037436 - Functional Exercise and Nutrition Education Program for Older Adults N/A
Recruiting NCT04703842 - Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction Phase 1/Phase 2
Terminated NCT05594940 - Heart Failure Monitoring With a Portable Ultrasound Device With Artificial Intelligence Assisted Tools: A Multi-Phase Observational Feasibility Study
Recruiting NCT04982081 - Treating Congestive HF With hiPSC-CMs Through Endocardial Injection Phase 1
Completed NCT04394754 - Evaluating Efficacy of Digital Health Technology in the Treatment of Congestive Heart Failure N/A
Active, not recruiting NCT01385176 - Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF) N/A
Not yet recruiting NCT05516290 - Evaluating Clinical Trial Experiences of Individuals With Congestive Heart Failure
Completed NCT02885636 - Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial Phase 3
Terminated NCT02788656 - Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan) Phase 4
Terminated NCT02205411 - Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation N/A
Completed NCT02252757 - Assess Measurements of Wireless Cardiac Output Device N/A
Completed NCT01362855 - Advance Care Planning Evaluation in Hospitalized Elderly Patients
Completed NCT01476995 - Prognostic Indicators as Provided by the EPIC ClearView N/A
Withdrawn NCT00346177 - Stem Cell Study for Patients With Heart Failure Phase 2
Active, not recruiting NCT01058837 - SCD-HeFT 10 Year Follow-up N/A
Completed NCT00957541 - Evaluation of a Diagnostic Feature in a Cardiac Resynchronization Therapy (CRT) Device Phase 2